- CEO
- Timothy Ryan Keogh
- Full Time Employees
- 3
- Sector
- Real Estate
- Industry
- Real Estate - Services
- Address
- 1555 Blake Street Denver CO United States of America 80202
- IPO Date
- Jul 10, 2014
- Business
- AmeriCann, Inc. (OTCQB: ACAN) designs, develops, leases and operates sustainable cannabis cultivation, processing and manufacturing facilities in the United States, utilizing its proprietary Cannopy System that combines traditional horticulture, lean manufacturing and regulatory compliance for efficient production of medical and adult-use cannabis; the company provides real estate acquisition and development services tailored for cannabis operations, licensing procurement assistance in competitive state processes, nationwide support networks of industry leaders and infused product formulation support including beverages, edibles, topicals and concentrates. Its flagship Massachusetts Cannabis Center in Freetown, Massachusetts, comprises a planned one million square feet of greenhouse cultivation and processing space across a 52.6-acre site, with the initial 30,000-square-foot Building 1 operational since 2020 for cultivation, extraction via CO2 and ethanol methods, and product manufacturing leased to licensed operators. Founded in 2010 and headquartered at 1555 Blake Street, Unit 502, Denver, Colorado, AmeriCann targets regulated markets serving dispensaries, patients and consumers through its Preferred Partner Program. The company reports four consecutive quarters of positive net income as of early 2023, alongside record fiscal year-end revenue and EBITDA growth; it secured a Host Community Agreement in Freetown in late 2024, hired Campanelli Construction as general contractor for facility expansions and launched national brand 1906 products at the Massachusetts Cannabis Center in 2021, while pursuing opportunities in California, Pennsylvania and Florida with $2 million in equity financing.